The researchers evaluated the treatment status of GLP-1 users every six months
This is why maintaining a healthy gut microbiome (the good bacteria in your gut) is important for regulating your appetite and metabolism
On May 2, 2026, The Lancet published a randomized, double-blind, placebo-controlled trial (Klausen et al., Copenhagen University Hospital) testing once-weekly semaglutide 2.4 mg in 108 treatment-seeking adults with moderate to severe alcohol use disorder and comorbid obesity
Food and Drug Administration) and EMA (European Medicines Agency) have introduced stringent new pharmaceutical packaging requirements to address three critical pillars: Cold-Chain Integrity , Anti-Counterfeiting , and Patient Safety
However, it is equally common to feel no significant difference initially, which does not indicate the medication is ineffective
doi: 10.1210/en.2011-0174 [DOI] [PMC free article] [PubMed] [Google Scholar] 33.Paternoster S, Falasca M